Stroke

ATTICUS subgroup analyses indicate superiority of apixaban over aspirin 5:43
ATTICUS subgroup analyses indicate superiority of apixaban over aspirin
Sven Poli • 20 Feb 2023
Natural history of pediatric large vessel occlusion stroke 1:34
Natural history of pediatric large vessel occlusion stroke
Kartik Bhatia • 27 Feb 2023
Gathering high-level evidence for thrombectomy in pediatric stroke 1:02
Gathering high-level evidence for thrombectomy in pediatric stroke
Kartik Bhatia • 27 Feb 2023
LACI-2: cilostazol and isosorbide mononitrate for the treatment of lacunar stroke 22:08
LACI-2: cilostazol and isosorbide mononitrate for the treatment of lacunar stroke
Joanna Wardlaw et al. • 23 Feb 2023
Protecting the endothelium as a therapeutic strategy in cerebral small vessel disease 5:05
Protecting the endothelium as a therapeutic strategy in cerebral small vessel disease
Joanna Wardlaw et al. • 23 Feb 2023
Non-contrast CT versus perfusion imaging for treatment decision making in ischemic stroke 1:26
Non-contrast CT versus perfusion imaging for treatment decision making in ischemic stroke
Marc Ribo • 13 Feb 2023
Endovascular thrombectomy remains underutilized 2:04
Endovascular thrombectomy remains underutilized
Xiaochuan Huo • 21 Feb 2023
Endovascular therapy vs medical management for large core ischemic stroke: ANGEL-ASPECT results 4:41
Endovascular therapy vs medical management for large core ischemic stroke: ANGEL-ASPECT results
Xiaochuan Huo • 21 Feb 2023
Who will benefit the most from tenecteplase for intravenous thrombolysis? 0:55
Who will benefit the most from tenecteplase for intravenous thrombolysis?
Shuya Li • 20 Feb 2023
TRACE II results: tenecteplase versus alteplase for IVT 2:05
TRACE II results: tenecteplase versus alteplase for IVT
Shuya Li • 20 Feb 2023
APRIL trial: ApTOLL demonstrates neuroprotective effects in acute ischemic stroke 8:02
APRIL trial: ApTOLL demonstrates neuroprotective effects in acute ischemic stroke
Marc Ribo • 13 Feb 2023
ARAMIS: dual antiplatelet therapy non-inferior to alteplase in minor ischemic stroke 4:46
ARAMIS: dual antiplatelet therapy non-inferior to alteplase in minor ischemic stroke
Thanh Nguyen • 15 Feb 2023
Defining the limits of EVT: MeVOs 1:22
Defining the limits of EVT: MeVOs
Marc Ribo • 13 Feb 2023
Key data at ISC 2023: DAPT vs IVT, alteplase vs tenecteplase, and EVT in large core stroke 3:43
Key data at ISC 2023: DAPT vs IVT, alteplase vs tenecteplase, and EVT in large core stroke
Thanh Nguyen • 15 Feb 2023
EVT versus medical management in patients with pre-stroke disability 2:14
EVT versus medical management in patients with pre-stroke disability
James E. Siegler • 13 Feb 2023
Managing basilar artery occlusion: stroke provider perspectives 1:43
Managing basilar artery occlusion: stroke provider perspectives
James E. Siegler • 13 Feb 2023
The content of VJNeurology is intended for healthcare professionals